Human Epidermal Growth Factor Receptor 2 Negative Tumor: Clinical Trials

1 trial for Human Epidermal Growth Factor Receptor 2 Negative Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. .

Follow Human Epidermal Growth Factor Receptor 2 Negative Tumor: new trials by email Literature Review of Human Epidermal Growth Factor Receptor 2 Negative Tumor trials Research Report on Human Epidermal Growth Factor Receptor 2 Negative Tumor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer
Observation - Primary Invasive Breast Cancer, Estrogen Receptor Positive Tumor
Active not recruitingNorth Eastern German Society of Gynaecological Oncology11912018-07-172026-04-13

Narrower conditions

Breast Neoplasms (1)

Broader conditions

Breast Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Observation (1)

Sponsors

North Eastern German Society of Gynaecological Oncology (1)

Countries

Germany (1)  ·  Switzerland (1)

Top investigators

Marion Kiechle, Prof. Dr. (1)